The Patient Experience of Steroid-toxicity and Shared Decision-making
Thirty-one patients with inflammatory and autoimmune diseases reported more than 100 steroid-related toxicities in a qualitative study published in the Journal of Neurological Sciences in 2024, and ...
Steroid-Toxicity in Children: The Case for a Pediatric GTI
An estimated 10% of children will receive steroids during their childhood. For many, the treatment is life-saving. For far too many, steroids leave a trail of growth inhibition, delayed puberty, mood ...
Mind the Measurement Gap
How health economics and outcomes research (HEOR) puts a value on steroid-toxicity A microsimulation model presented at ISPOR Europe 2025 put a number on the lifetime clinical and economic burden of ...
The Glucocorticoid Toxicity Index: Measuring Change in Trials and Practice
For decades, nearly 70 distinct toxicities have been attributed to long-term glucocorticoid use. Yet, until the Glucocorticoid Toxicity Index (GTI) arrived, clinicians had no standardized, validated ...
From Target Product Profile to Label Value
A drug that costs more than $50,000 per year needs a better argument than "it reduces prednisone by a few milligrams." That argument works if the developer has designed the trial to capture it. Most ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
